Posted on September 23, 2009 by Debra A. McCurdy

Drug/Biologics Firm Performance Regarding Postmarketing Requirements

The FDA has released its annual report on the status of drug and biological product postmarketing studies and clinical trials, as required by the Food and Drug Administration Modernization Act of 1997.

Tags: , , ,
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.healthindustrywashingtonwatch.com/admin/trackback/157283
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.